Inserm Transfert ensures the promotion and value creation for inventions, materials, know-how and expertise from its laboratories and the related clinical skills. Inserm Transfert sets up a variety of solutions to meet the ever more demanding requirements of companies, either through conventional licence agreements and collaboration agreements, or tailored alliances involving several laboratories and expertise. Everything is done to respond as closely as possible to companies’ requirements.
Inserm Transfert offers access to a rich assets ranging from the expertise of KOL, scientists and clinicians, to innovations obtained from basic translational and clinical research (new targets, signalling pathways etc.), know-how, research, technological & infrastructure platforms, databases, patient or subject cohorts, biobanks, technological research accelerators for ultrasound, bio printing and organ reconstruction, Inserm, multi-team transverse programmes on the microbiota, ageing and genetic variability.
Consult Inserm’s areas of strategic innovation => here